PL170592B1 - Method of determining cytokin inducing activity of immunologically active substances and composition therefor - Google Patents

Method of determining cytokin inducing activity of immunologically active substances and composition therefor

Info

Publication number
PL170592B1
PL170592B1 PL92303417A PL30341792A PL170592B1 PL 170592 B1 PL170592 B1 PL 170592B1 PL 92303417 A PL92303417 A PL 92303417A PL 30341792 A PL30341792 A PL 30341792A PL 170592 B1 PL170592 B1 PL 170592B1
Authority
PL
Poland
Prior art keywords
formula
bis
phenyldiselenide
culture
cytokines
Prior art date
Application number
PL92303417A
Other languages
English (en)
Polish (pl)
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of PL170592B1 publication Critical patent/PL170592B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL92303417A 1991-10-26 1992-09-28 Method of determining cytokin inducing activity of immunologically active substances and composition therefor PL170592B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (1)

Publication Number Publication Date
PL170592B1 true PL170592B1 (en) 1997-01-31

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
PL92303417A PL170592B1 (en) 1991-10-26 1992-09-28 Method of determining cytokin inducing activity of immunologically active substances and composition therefor

Country Status (22)

Country Link
US (1) US5543300A (enEXAMPLES)
EP (2) EP0539610A1 (enEXAMPLES)
JP (1) JPH07500905A (enEXAMPLES)
AT (1) ATE153763T1 (enEXAMPLES)
AU (1) AU678343B2 (enEXAMPLES)
BG (1) BG61705B1 (enEXAMPLES)
CA (1) CA2122131A1 (enEXAMPLES)
CZ (1) CZ100494A3 (enEXAMPLES)
DE (3) DE539610T1 (enEXAMPLES)
DK (1) DK0609255T3 (enEXAMPLES)
ES (1) ES2061424T3 (enEXAMPLES)
FI (1) FI941920A0 (enEXAMPLES)
GR (3) GR930300100T1 (enEXAMPLES)
HU (1) HU216863B (enEXAMPLES)
LV (1) LV12140B (enEXAMPLES)
NO (1) NO941444L (enEXAMPLES)
PL (1) PL170592B1 (enEXAMPLES)
RO (1) RO114837B1 (enEXAMPLES)
RU (1) RU2125727C1 (enEXAMPLES)
SG (1) SG72665A1 (enEXAMPLES)
SK (1) SK44094A3 (enEXAMPLES)
WO (1) WO1993008470A1 (enEXAMPLES)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
WO2000016785A2 (en) * 1998-09-23 2000-03-30 Enerkom (Proprietary) Limited Humic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DE60304989T2 (de) * 2003-02-18 2007-03-29 Clinique La Prairie Research S.A. Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
EP2753422A1 (en) 2011-09-07 2014-07-16 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
ATE77488T1 (de) * 1986-03-06 1992-07-15 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
ATE131859T1 (de) * 1991-03-16 1996-01-15 Torf Ets Verfahren zur kontinuierlichen extraction von torf und apparat zur durchführung dieses verfahrens

Also Published As

Publication number Publication date
US5543300A (en) 1996-08-06
HU216863B (hu) 1999-09-28
ES2061424T3 (es) 1997-10-01
HK1002610A1 (en) 1998-09-04
CZ100494A3 (en) 1994-11-16
SK44094A3 (en) 1995-03-08
EP0609255A1 (en) 1994-08-10
LV12140B (lv) 1998-12-20
DE69220078D1 (de) 1997-07-03
DE539610T1 (de) 1993-12-16
AU2650992A (en) 1993-05-21
LV12140A (lv) 1998-09-20
GR940300077T1 (en) 1994-11-30
DK0609255T3 (da) 1997-12-22
JPH07500905A (ja) 1995-01-26
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
GR930300100T1 (enEXAMPLES) 1993-10-29
RO114837B1 (ro) 1999-07-30
ATE153763T1 (de) 1997-06-15
BG61705B1 (bg) 1998-03-31
HUT69990A (en) 1995-09-28
RU94022481A (ru) 1996-09-27
BG98720A (bg) 1995-07-28
HU9401185D0 (en) 1994-07-28
ES2061424T1 (es) 1994-12-16
CA2122131A1 (en) 1993-04-29
WO1993008470A1 (en) 1993-04-29
NO941444L (no) 1994-06-16
SG72665A1 (en) 2000-05-23
RU2125727C1 (ru) 1999-01-27
FI941920A7 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
GR3024457T3 (en) 1997-11-28
EP0539610A1 (en) 1993-05-05
EP0609255B1 (en) 1997-05-28
FI941920L (fi) 1994-04-25
NO941444D0 (no) 1994-04-21
FI941920A0 (fi) 1994-04-25

Similar Documents

Publication Publication Date Title
McCormick et al. Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium
MacLean et al. Host resistance in sepsis and trauma
Wilton et al. Cell-mediated immunity in Herpesvirus hominis infections
Niemialtowski et al. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis.
EPERON et al. Susceptibility of B‐cell deficient C57BL/6 (μMT) mice to Neospora caninum infection
Waller Sensitivity of Encephalitozoon cuniculi to various temperatures, disinfectants and drugs
PL170592B1 (en) Method of determining cytokin inducing activity of immunologically active substances and composition therefor
Chongsuphajaisiddhi et al. In vivo and in vitro sensitivity of falciparum malaria to quinine in Thai children
Roberts Jr et al. Hyperthermia and human leukocyte function: II. Enhanced production of and response to leukocyte migration inhibition factor (LIF)
RU2167659C1 (ru) Способ коррекции иммунной системы живого организма
Gardner et al. Monocyte function in ageing humans
Van Pham et al. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies
Argov et al. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome
JPH01110633A (ja) 肝細胞刺激因子
Turco et al. Comparison of the properties of antirickettsial activity and interferon in mouse lymphokines
US4499093A (en) Interferon induction method
ES2208705T3 (es) Procedimiento de investigacion de pirogenos.
De Simone et al. Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human γ-interferon production and blastogenesis
RU2027434C1 (ru) Иммуномодулирующее средство
RU2198166C2 (ru) 2,4-диоксо-5-арилиденимино-1,3-пиримидины
HK1002610B (en) Method and composition for determining the immunological activity of bioactive substances
RU2169732C1 (ru) Производные 5-оксо-5н-[1]-бензопирано-[5,6-b]4-оксо-4н-[1,2]-пиримидо-1,4,5,6-тетрагид ро-1,3-тиазина
RU2199526C2 (ru) Арил- и гетериламиды карбоалкоксисульфаниловых кислот
WO1998043982A1 (en) Tetracyclical derivatives from pyrimidine
Francoeur et al. PIF, a highly sensitive plaque assay for the induction of interferon